Document is current
Any future updates will be listed below
-
Authors
Landau, Dan A.
Sun, Clare https://orcid.org/0000-0001-8498-4729
Rosebrock, Daniel
Herman, Sarah E. M.
Fein, Joshua
Sivina, Mariela
Underbayev, Chingiz
Liu, Delong
Hoellenriegel, Julia
Ravichandran, Sarangan
Farooqui, Mohammed Z. H.
Zhang, Wandi
Cibulskis, Carrie
Zviran, Asaf
Neuberg, Donna S. https://orcid.org/0000-0003-2566-3145
Livitz, Dimitri https://orcid.org/0000-0003-2528-1446
Bozic, Ivana
Leshchiner, Ignaty https://orcid.org/0000-0001-8942-9265
Getz, Gad https://orcid.org/0000-0002-0936-0753
Burger, Jan A.
Wiestner, Adrian
Wu, Catherine J.
- License Information
-
More Information
Article History
Received: 4 July 2017
Accepted: 20 November 2017
First Online: 19 December 2017
Competing interests
: C.J.W. is founder of Neon Therapeutics and a member of its scientific advisory board. A.W. and J.A.B. received research funding from Pharmacyclics, an Abbvie Company. J.A.B. received research funding from Gilead. A.W. received research funding from Acerta Pharma. The remaining authors declare no competing financial interests.
